My site

(BUSINESS WIRE) -- BYD, the global leading new energy vehicle (NEV) manufacturer, presented its new luxury model BYD Seal and the limited edition of BYD ATTO 3 in its iconic color Forest Green at the Indian Auto Expo 2023. BYD Seal, whose sales have exceeded 50,000 within 5 months in China, is planned to be launched in India by Q4 2023. As the All-New e6 and BYD ATTO 3 are already available in the local market, BYD Seal will be the third passenger EV released in India within two years.

At the Auto Expo 2023, BYD’s display space is sectioned into 4 zones, which showcase not only its current and new vehicle products but also technological innovations that substantially enhance the performance and safety of vehicles. These newly-unveiled products and innovation displays echo the Indian-specific theme at the convention: Technological Innovations For A Better Life.

BYD SEAL

BYD Seal is one of BYD’s latest luxury sedans equipped with its renowned EV pla ... Read more »

DALLAS - Friday, 13. January 2023

Sharjah, United Arab Emirates - Friday, 13. January 2023
 

Sharjah Finance Department (SFD) concluded an introductory seminar in the Arab Republic of Egypt on the second cycle of the Sharjah Award for Public Finance.  The seminar was part of a series of second-phase meetings scheduled to conclude at the end of January 2023.

Distinguished representatives of government agencies and sectors in Egypt

The symposium was sponsored by His Excellency Dr Mohamed Maait, Minister of Finance of the Arab Egyptian public, and was attended by Dr Ahmed Kajouk, Deputy Minister of Finance for Financial Policies and Institutional Development in Egypt, and His Excellency Dr Nasser Al Hatlan Al Qahtani, Director General of the Arab Organization for Administrative Development affiliated to the League of Arab States, Vice-Chairman of the Board of Trustees of the Award. His Excellency Waleed Al Sayegh, Director General of SFD, member of the Board of Trustees of the Aw ... Read more »

OSAKA, Japan & CAMBRIDGE, Mass. & PASADENA, Calif. - Monday, 09. January 2023

− Fibrosis regression observed in 50% of patients receiving fazirsiran

− Median reductions of 94% of Z-AAT accumulation in the liver and mean reduction of 68% in histologic globule burden

− Treatment emergent adverse events were generally well balanced between fazirsiran and placebo groups

− Results consistent with AROAAT-2002 open-label study previously published in The New England Journal of Medicine

− Arrowhead to host webcast investor call today, January 9, 2023, at 8:30 a.m. ET

(BUSINESS WIRE) -- Takeda (TSE:4502/NYSE:TAK) and Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced topline results from the Phase 2 SEQUOIA clinical study of investigational fazirsiran (TAK-999/ARO-AAT) for the treatment of liver disease associated with alpha-1 antitrypsin deficiency (AATD-LD). The companies also provided an ... Read more »

KAMPALA, Uganda - Friday, 13. January 2023

(BUSINESS WIRE) -- AIDS Healthcare Foundation (AHF), the largest global HIV/AIDS organization, hailed today the Government of Uganda’s heroic efforts in successfully controlling the Ebola Sudan virus (a rare strain of the virus) outbreak, after Uganda's Minister for Health, Dr Jane Aceng, officially declared the nation Ebola-free during a ceremony to mark the end of the outbreak. This declaration comes after the East African country has gone 42 days with no active cases, in line with standards set by the World Health Organisation (WHO).

"I salute Uganda for so effectively controlling this outbreak despite the fact that it invaded its largest city. Rich countries with an abundance of resources could learn a lot from Uganda,” said Michael Weinstein, President of AIDS Healthcare Foundation.

The outbreak, which began about four months ago, affected five districts, including Mubende (the epicentre) an ... Read more »